222 related articles for article (PubMed ID: 18532922)
21. Novel topical drug delivery systems and their potential use in acne vulgaris.
Taglietti M; Hawkins CN; Rao J
Skin Therapy Lett; 2008 Jun; 13(5):6-8. PubMed ID: 18648713
[TBL] [Abstract][Full Text] [Related]
22. The effect of vehicle formulation on acne medication tolerability.
Draelos ZD; Callender V; Young C; Dhawan SS
Cutis; 2008 Oct; 82(4):281-4. PubMed ID: 19055172
[TBL] [Abstract][Full Text] [Related]
23. Erythema-directed digital photography for the enhanced evaluation of topical treatments for acne vulgaris.
Micali G; Dall'Oglio F; Tedeschi A; Lacarrubba F
Skin Res Technol; 2018 Aug; 24(3):440-444. PubMed ID: 29383779
[TBL] [Abstract][Full Text] [Related]
24. Topical agents alone in acne. A blind assessment study.
Swinyer LJ; Swinyer TA; Britt MR
JAMA; 1980 Apr; 243(16):1640-3. PubMed ID: 6444678
[TBL] [Abstract][Full Text] [Related]
25. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
Dhawan SS
Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
[TBL] [Abstract][Full Text] [Related]
26. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity.
Gupta A; Singh S; Kotla NG; Webster TJ
Int J Nanomedicine; 2015; 10():171-82. PubMed ID: 25565812
[TBL] [Abstract][Full Text] [Related]
27. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
28. Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne.
McKeage K; Keating GM
Am J Clin Dermatol; 2008; 9(3):193-204. PubMed ID: 18429651
[TBL] [Abstract][Full Text] [Related]
29. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
Warner GT; Plosker GL
Am J Clin Dermatol; 2002; 3(5):349-60. PubMed ID: 12069641
[TBL] [Abstract][Full Text] [Related]
30. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Draelos ZD; Potts A; Alió Saenz AB;
Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
[TBL] [Abstract][Full Text] [Related]
31. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
Bowman S; Gold M; Nasir A; Vamvakias G
J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
[TBL] [Abstract][Full Text] [Related]
32. A look at emerging delivery systems for topical drug products.
Fireman S; Toledano O; Neimann K; Loboda N; Dayan N
Dermatol Ther; 2011; 24(5):477-88. PubMed ID: 22353154
[TBL] [Abstract][Full Text] [Related]
33. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid].
Worret WI; Fluhr JW
J Dtsch Dermatol Ges; 2006 Apr; 4(4):293-300. PubMed ID: 16638058
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne.
Seidler EM; Kimball AB
J Am Acad Dermatol; 2011 Oct; 65(4):e117-e119. PubMed ID: 21816505
[No Abstract] [Full Text] [Related]
35. Topical antibacterial therapy for acne vulgaris.
Dreno B
Drugs; 2004; 64(21):2389-97. PubMed ID: 15481998
[TBL] [Abstract][Full Text] [Related]
36. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
[TBL] [Abstract][Full Text] [Related]
37. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product.
Leyden JJ; Hickman JG; Jarratt MT; Stewart DM; Levy SF
J Cutan Med Surg; 2001; 5(1):37-42. PubMed ID: 11281433
[TBL] [Abstract][Full Text] [Related]
38. Targeted clindamycin delivery to pilosebaceous units by chitosan or hyaluronic acid nanoparticles for improved topical treatment of acne vulgaris.
Tolentino S; Pereira MN; Cunha-Filho M; Gratieri T; Gelfuso GM
Carbohydr Polym; 2021 Feb; 253():117295. PubMed ID: 33278954
[TBL] [Abstract][Full Text] [Related]
39. Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review.
Taylor GA; Shalita AR
Am J Clin Dermatol; 2004; 5(4):261-5. PubMed ID: 15301572
[TBL] [Abstract][Full Text] [Related]
40. [Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy].
Fluhr JW; Degitz K
J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S24-30. PubMed ID: 20482689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
